|本期目录/Table of Contents|

[1]孟丽红,姜良铎,张晓梅.肺间质纤维化瘀血证微观探讨[J].环球中医药,2017,10(10):1102-1104.[doi:10.3969/j.issn.1674-1749.2017.10.010]
　MENG Lihong,JIANG Liangduo,ZHANG Xiaomei..Microscopic study of blood stasis syndrome of pulmonary interstitial fibrosis[J].,2017,10(10):1102-1104.[doi:10.3969/j.issn.1674-1749.2017.10.010]
点击复制

肺间质纤维化瘀血证微观探讨()
     
分享到：

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第10卷
期数:
2017年10期
页码:
1102-1104
栏目:
理论探讨
出版日期:
2017-10-06

文章信息/Info

Title:
Microscopic study of blood stasis syndrome of pulmonary interstitial fibrosis
作者:
孟丽红; 姜良铎; 张晓梅
100070 北京中医药大学第二临床医学院[孟丽红(博士研究生)]; 北京中医药大学东方医院呼吸热病科(姜良铎、张晓梅)
Author(s):
MENG Lihong; JIANG Liangduo;  ZHANG Xiaomei.
Beijing University of Chinese Medicine, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100029, China
关键词:
肺间质纤维化;  瘀血;  肺微血管变化;  凝血纤溶系统失衡
Keywords:
Pulmonary fibrosis;  Blood stasis;  Pulmonary microvascular change;  Imbalance of coagulation and fibrinolysis system
分类号:
R256.1
DOI:
10.3969/j.issn.1674-1749.2017.10.010
文献标志码:
A
摘要:
肺间质纤维化是呼吸系统的难治性疾病,临床发现肺间质纤维化患者存在显著的瘀血证,瘀血闭阻肺中络脉是肺间质纤维化发病的重要病机。现代研究证实肺微血管变化和凝血纤溶系统失衡是肺纤维化血瘀证的微观病理基础。本文拟从中西医角度探讨肺间质纤维化瘀血证的产生机理及微观病变,旨在为临床治疗肺间质纤维化提出一个新的思路。
Abstract:
Pulmonary interstitial fibrosis is a refractory disease of the respiratory system. It is found that there is a significant blood stasis syndrome in patients with pulmonary fibrosis, blood stasis obstructs the collaterals of the lung is an important pathogenesis of pulmonary fibrosis. Modern studies have proved that the changes of pulmonary microvasculature and imbalance of coagulation and fibrinolysis system are the microscopic pathological basis of blood stasis syndrome in pulmonary fibrosis. This article intends to discuss the pathogenesis and microscopic pathological changes of blood stasis syndrome in pulmonary interstitial fibrosis from the angle of traditional Chinese medicine and western medicine, in order to put forward a new train of thought for clinical treatment of pulmonary interstitial fibrosis.

参考文献/References:

[1] 王立娟,贾新华.肺纤维化从瘀论治探析[J].天津中医药大学学报, 2012, 31(4):200-201.
[2] 舒燕萍,丁兆辉. 浅论从瘀论治肺间质纤维化[J]. 江西中医药, 2013,(11):12-13.
[3] 姜良铎,张晓梅,肖培新.特发性肺间质纤维化的病因病机探讨[J]. 中华中医药杂志, 2008,(11):984-986.
[4] 刘旻,赵启亮,刘贵颖,等.从“邪伏肺络、因瘀致虚”析特发性肺纤维化[J].世界中医药, 2016,11(8):1559-1561.
[5] 刘创,庞立健,吕晓东.特发性肺纤维化“肺虚络瘀”病机发微[J].上海中医药杂志,2014, 48(3):22-24.
[6] Keane M P,Strieter R M, Rd L J, et al. Inflammation and angiogenesis in fibrotic lung disease.[J]. Semin Respir Crit Care Med, 2006, 27(6):589-599.
[7] Voelkel N F, Douglas I S, Nicolls M. Angiogenesis in Chronic Lung Disease[J]. Chest, 2007, 131(3):874-879.
[8] Richeldi L,Du B R,Raghu G,et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.[J]. New England Journal of Medicine,2014,370(22):2071.
[9] 颜林枫,南海燕,崔光彬,等. 肺微血管内皮细胞表型改变与博菜霉素所致大鼠肺纤维化的关系[J]. 医学争鸣,2008,(16):1458-1461.
[10] 王晨,王紫娟,张晓梅,等.肺纤方提取物对肺间质纤维化大鼠血管新生的影响[J]. 北京中医药大学学报,2017,40(1): 36-40.
[11] 刘哲,张晓梅,秦慧慧,等. 肺纤方对肺间质纤维化大鼠VEGF及VEGFR1、VEGFR2基因表达的影响[J]. 北京中医药大学学报,2014,(11):753-757.
[12] 刘哲,张晓梅,秦慧慧,等.肺纤方提取物干预肺纤维化大鼠及肺微血管内皮细胞体外培养研究[J]. 北京中医药大学学报,2014,38(4):233-252.
[13] 王晨,王紫娟,张晓梅,等. 肺纤方提取物对肺间质纤维化大鼠血管新生的影响[J].北京中医药大学学报,2017,40(1):36-40.
[14] Gyori D,Chessa T,Hawkins P,et al. Class(I)Phosphoinositide 3-Kinases in the Tumor Microenvironment[J]. Cancers,2017,9(3):24.
[15] Nimlamool W,Andrews R M,Falk M M. Connexin43 phosphorylation by PKC and MAPK signals VEGF-mediated gap junction internalization[J]. Mol Biol Cell,2015,26(15):2755-2768.
[16] Molkentin J D,Bugg D,Ghearing N,et al. Fibroblast-Specific Genetic Manipulation of p38 MAPK in vivo Reveals its Central Regulatory Role in Fibrosis[J]. Circulation,2017,136(6):549-561.
[17] Mishra A,Stueckle T A,Mercer R R,et al. Identification of TGF-beta receptor-1 as a key regulator of carbon nanotube-induced fibrogenesis[J]. Am J Physiol Lung Cell Mol Physiol, 2015,309(8):L821-L833.
[18] 朱玉龙,张建,朱玉虎,等.肺间质纤维化患者血流变、凝血功能变化与中医证型相关性分析[J].时珍国医国药,2013,24(2):493-494.
[19] 韩昆鹏,潘文森.特发性肺纤维化的发病机制及凝血指标与肺功能关系的研究[J].贵州医药,2014,38(12):1070-1072.
[20] Malouf MA,Hopkins P,Snell G,et al. An investigatordriven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis[J]Respirology,2011,16(3):776-783.
[21] 刘哲,张晓梅,秦慧慧,等.肺纤方提取物对肺间质纤维化大鼠VCAM-1、PAI-1 mRNA的影响[J].中国实验方剂学杂志,2015,21(7):107-110.
[22] 李蕾,王培昌.蛋白C抗凝系统及生物学作用最新研究进展[J].四川医学,2012,33(9):1685-1687.

相似文献/References:

[1]张丽霞,陈大权.从血瘀辨治口干验案1则[J].环球中医药,2012,5(06):452.
[2]李守然,范婷.张根腾运用活血化瘀法论治肾性血尿[J].环球中医药,2012,5(09):699.
[3]张晓雷 马家驹 蔡永登 王玉光.从古文献探讨肺间质纤维化的治疗思路[J].环球中医药,2017,10(03):351.[doi:10.3969/j.issn.1674-1749.2017.03.030]

备注/Memo

备注/Memo:
基金项目: 国家自然科学基金(81273696)
作者简介:孟丽红(1989- ),女,2016级在读博士研究生。研究方向:中医药治疗呼吸系统疾病。E-mail:menglh806@qq.com
通信作者:张晓梅(1966- ),女,博士,主任医师,博士生导师。研究方向:中医药治疗呼吸系统疾病。E-mail:Zhangxim6767@sina.com
更新日期/Last Update: 2017-10-06